Maarten Boers Selected Research

Sulfasalazine (Azulfidine)

1/2020	EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
6/2017	EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.
6/2015	Intensive combination treatment regimens, including prednisolone, are effective in treating patients with early rheumatoid arthritis regardless of additional etanercept: 1-year results of the COBRA-light open-label, randomised, non-inferiority trial.
1/2015	Initial high-dose prednisolone combination therapy using COBRA and COBRA-light in early rheumatoid arthritis.
6/2014	A non-inferiority trial of an attenuated combination strategy ('COBRA-light') compared to the original COBRA strategy: clinical results after 26 weeks.
2/2010	The selective estrogen receptor alpha agonist Org 37663 induces estrogenic effects but lacks antirheumatic activity: a phase IIa trial investigating efficacy and safety of Org 37663 in postmenopausal female rheumatoid arthritis patients receiving stable background methotrexate or sulfasalazine.
11/2007	Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment.
7/2007	Why are Dutch rheumatologists reluctant to use the COBRA treatment strategy in early rheumatoid arthritis?
9/2004	Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone.
2/2003	Radiologic features in juvenile idiopathic arthritis: a first step in the development of a standardized assessment method.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maarten Boers Research Topics

Disease

85	Rheumatoid Arthritis 11/2022 - 02/2002
10	Rheumatic Diseases (Rheumatism) 06/2022 - 12/2012
9	Arthritis (Polyarthritis) 01/2021 - 03/2007
8	Inflammation (Inflammations) 06/2022 - 02/2009
6	Pain (Aches) 01/2020 - 06/2014
6	Neoplasms (Cancer) 11/2019 - 04/2002
5	Vasculitis (Vasculitides) 11/2015 - 10/2009
5	Osteoarthritis 09/2015 - 05/2007
4	Necrosis 01/2020 - 03/2013
4	Ankylosing Spondylitis 04/2015 - 05/2007
3	COVID-19 06/2022 - 11/2021
3	Psoriatic Arthritis 01/2022 - 08/2009
3	Synovitis 01/2022 - 09/2015
3	Infections 01/2022 - 01/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2014
3	Osteoporosis 02/2016 - 05/2007
3	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 03/2014 - 07/2011
3	Ulcer 10/2007 - 04/2004
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2006 - 04/2002
2	Axial Spondyloarthritis 01/2022 - 01/2020
2	Autoimmune Diseases (Autoimmune Disease) 11/2021 - 09/2015
2	Arthralgia (Joint Pain) 01/2021 - 04/2016
2	Fatigue 01/2020 - 02/2013
2	Carcinoma (Carcinomatosis) 02/2016 - 11/2007
2	Margins of Excision 02/2016 - 11/2007
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 11/2015 - 07/2011
2	Peptic Ulcer (Peptic Ulcers) 12/2007 - 10/2007
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 11/2007 - 02/2003
1	Musculoskeletal Diseases (Musculoskeletal Disease) 06/2022
1	Breakthrough Infections 06/2022
1	AIDS-Related Complex (ARC) 06/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Retinal Vasculitis 08/2021
1	Choroiditis 08/2021
1	Anterior Uveitis 08/2021
1	Lymphoma (Lymphomas) 11/2019
1	Lung Neoplasms (Lung Cancer) 11/2019

Drug/Important Bio-Agent (IBA)

23	GlucocorticoidsIBA 10/2022 - 02/2004
14	Biological ProductsIBA 01/2022 - 01/2010
12	Methotrexate (Mexate)FDA LinkGeneric 11/2021 - 02/2002
11	Antirheumatic Agents (DMARD)IBA 06/2021 - 05/2007
11	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020 - 02/2002
10	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 02/2002
10	Adalimumab (Humira)FDA Link 06/2021 - 09/2011
9	Abatacept (Orencia)FDA Link 01/2020 - 06/2006
8	Biomarkers (Surrogate Marker)IBA 01/2019 - 03/2007
6	Etanercept (Enbrel)FDA Link 01/2020 - 02/2012
6	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2015 - 03/2007
5	Pharmaceutical PreparationsIBA 02/2016 - 10/2002
4	C-Reactive ProteinIBA 06/2022 - 03/2007
4	Rituximab (Mabthera)FDA Link 01/2020 - 04/2012
4	tocilizumab (atlizumab)FDA Link 01/2020 - 06/2010
4	Tumor Necrosis Factor InhibitorsIBA 01/2020 - 03/2013
4	Prednisone (Sone)FDA LinkGeneric 10/2015 - 01/2012
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 05/2012 - 04/2002
3	Biosimilar PharmaceuticalsIBA 01/2020 - 03/2014
3	Infliximab (Remicade)FDA Link 01/2020 - 03/2014
3	Certolizumab Pegol FDA Link 01/2020 - 03/2014
3	golimumab FDA Link 01/2020 - 03/2014
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 08/2007
2	AntibodiesIBA 06/2022 - 01/2022
2	COVID-19 VaccinesIBA 05/2022 - 11/2021
2	Rheumatoid FactorIBA 01/2021 - 04/2016
2	sarilumabIBA 01/2020 - 06/2017
2	baricitinibIBA 01/2020 - 06/2017
2	tofacitinibIBA 01/2020 - 06/2017
2	Janus Kinase InhibitorsIBA 01/2020 - 06/2017
2	Leflunomide (Arava)FDA LinkGeneric 01/2020 - 06/2017
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2020 - 03/2007
2	Janus KinasesIBA 01/2020 - 06/2017
2	amsonic acid (DAS)IBA 01/2017 - 02/2016
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2015 - 03/2014
2	AutoantibodiesIBA 09/2015 - 07/2011
1	Immunosuppressive Agents (Immunosuppressants)IBA 06/2022
1	AntigensIBA 06/2022
1	N 30IBA 01/2022
1	(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA 01/2022
1	secukinumabIBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Immunomodulating AgentsIBA 01/2022
1	VaccinesIBA 11/2021
1	Immunoglobulin G (IgG)IBA 11/2021
1	Retinaldehyde (Retinal)IBA 08/2021
1	Colchicine FDA LinkGeneric 01/2021
1	Atorvastatin (Lipitor)FDA Link 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	canakinumab FDA Link 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	GLPG0634IBA 01/2020
1	upadacitinibIBA 01/2020
1	Prostaglandins AIBA 01/2020

Therapy/Procedure

41	Therapeutics 01/2022 - 02/2002
2	Phototherapy (Light Therapy) 01/2017 - 06/2015
2	General Anesthesia 02/2016 - 11/2007
2	Laryngectomy 02/2016 - 11/2007
2	Radiotherapy 02/2016 - 11/2007
2	Balneology 04/2015 - 06/2008
2	Thoracotomy 04/2006 - 04/2002
1	Ambulatory Care (Outpatient Care) 11/2022
1	CARE protocol 02/2020